Karen Worley, PhD, MS

GlaxoSmithKline, US Value, Evidence and Outcomes
Wyoming, OH, United States

Director – Specialty/Immunology

US Value, Evidence and Outcomes (US VEO)

Disclosure information not submitted.

Presentation(s):

• 0347: Real-World Effectiveness of Belimumab in Patients with SLE in the United States

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time